Skip to main content
. 2019 Nov 4;41(4):546–553. doi: 10.1038/s41401-019-0315-8

Fig. 5.

Fig. 5

Effects of UII and urantide on VCAM-1 and ICAM-1 expression in HUVECs (ae). Dose dependent mRNA levels of VCAM-1 and ICAM-1 (a, b); protein expression levels of VCAM-1 and ICAM-1 after treatment with 50 nM UII with or without urantide (n = 3 for each group) (c, d, e); and plasma UII levels in CAD patients (n = 24 for males and n = 16 for females) (f). Data are expressed as the mean ± SEM. *P < 0.05 and **P < 0.01